Clinical care of pregnant women with epilepsy: neural tube defects and folic acid supplementation
- PMID: 12790884
Clinical care of pregnant women with epilepsy: neural tube defects and folic acid supplementation
Erratum in
- Epilepsia. 2003 Nov;44(11):1465
Abstract
Women with epilepsy (WWE) have a risk of bearing children with congenital malformations that is approximately twice that of the general population. Most antiepileptic drugs (AEDs) have been associated with such risk. Valproate and carbamazepine have been associated specifically with the development of neural tube defects (NTDs), especially spina bifida. Other factors may contribute to the risk, including concomitant diseases such as diabetes mellitus, occupational exposure to teratogens, excessive prepregnancy weight, and various nutrient deficiencies. In the general population, maternal folate deficiency, in particular, has been linked with the development of NTDs, and periconceptional folate supplementation with a reduction of risk. It is unclear whether folate supplementation has a comparable protective effect for WWE. Data concerning the risk for congenital malformations associated with the newer AEDs (gabapentin, felbamate, lamotrigine, levetiracetam, oxcarbazepine, tiagabine, topiramate, and zonisamide) are still limited. Several pregnancy registries for women taking AEDs have been established. Comprehensive postmarketing surveillance, regionally or nationally, might be the ideal method of monitoring medication safety, but government support for such an undertaking has for the most part been lacking. Despite uncertainty about the efficacy of periconceptional folate supplementation in WWE, these women should receive such supplementation at dosage levels recommended for the general population of women of childbearing age. Seizure control must not be neglected in a pregnant woman with epilepsy since seizures are associated with harm to the fetus as well as the mother. Risk may be minimized by using a single AED at the lowest effective dosage.
Similar articles
-
Contraception, pregnancy and lactation in women with epilepsy.Baillieres Clin Neurol. 1996 Dec;5(4):887-908. Baillieres Clin Neurol. 1996. PMID: 9068887 Review.
-
Management issues for women with epilepsy: neural tube defects and folic acid supplementation.Neurology. 2003 Sep 1;61(6 Suppl 2):S23-6. doi: 10.1212/wnl.61.6_suppl_2.s23. Neurology. 2003. PMID: 14504306 Review.
-
Epilepsy and pregnancy.Epilepsia. 2004;45 Suppl 8:37-41. doi: 10.1111/j.0013-9580.2004.458008.x. Epilepsia. 2004. PMID: 15610193 Review.
-
[Should folic acid be given to women treated with valproic acid and/or carbamazepine? Folic acid and pregnancy in epilepsy].Rev Neurol (Paris). 1999 Mar;155(3):220-4. Rev Neurol (Paris). 1999. PMID: 10339792 French.
-
Pregnancy in women who have epilepsy.Neurol Clin. 2004 Nov;22(4):799-820. doi: 10.1016/j.ncl.2004.07.004. Neurol Clin. 2004. PMID: 15474768 Review.
Cited by
-
Antiepileptic drugs and pregnancy outcomes.Am J Med Genet A. 2012 Aug;158A(8):2071-90. doi: 10.1002/ajmg.a.35438. Epub 2012 Jun 18. Am J Med Genet A. 2012. PMID: 22711424 Free PMC article. Review.
-
Effects of Levetiracetam on neural tube development and closure of the chick embryos in ovo.Childs Nerv Syst. 2012 Jul;28(7):969-76. doi: 10.1007/s00381-012-1758-0. Epub 2012 May 9. Childs Nerv Syst. 2012. PMID: 22570165
-
Teratogenic effects of antiepileptic drugs.Expert Rev Neurother. 2010 Jun;10(6):943-59. doi: 10.1586/ern.10.57. Expert Rev Neurother. 2010. PMID: 20518610 Free PMC article. Review.
-
Antiepileptic drugs during pregnancy: what is known and which AEDs seem to be safest?Epilepsia. 2008 Dec;49 Suppl 9(0 9):43-55. doi: 10.1111/j.1528-1167.2008.01926.x. Epilepsia. 2008. PMID: 19087117 Free PMC article. Review.
-
Efavirenz use during pregnancy and for women of child-bearing potential.AIDS Res Ther. 2006 Apr 7;3:11. doi: 10.1186/1742-6405-3-11. AIDS Res Ther. 2006. PMID: 16603057 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical